Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Randomized, Double-blind, Two-arm Study Comparing the Efficacy and Safety of Trazodone Contramid® OAD and Placebo in the Treatment of Unipolar Major Depressive Disorder.

NCT00775203 is registered in ClinicalTrials.gov with Labopharm Inc. as lead sponsor.

NCT NCT00775203
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00775203 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Randomized, Double-blind, Two-arm Study Comparing the Efficacy and Safety of Trazodone Contramid® OAD and Placebo in the Treatment of Unipolar Major Depressive Disorder.
Lead sponsor
Labopharm Inc.
Phase
Phase 3
Overall status
Completed
Start date
June 30, 2007
Completion date
November 30, 2007
Enrollment
412 (actual)
Sites
36

Conditions

As the registry lists them; a condition with its own page is linked.

major depressive disorder